Back to Authors

Brady, Kathleen T.

https://orcid.org/0000-0002-3944-8051

Mayo Clinic

Medical University of South Carolina

Citations 2

Comparative Profiles of Men and Women with Opioid Dependence: Results from a National Multisite Effectiveness Trial
Payne, Rebecca, Wahlquist, Amy H. , Carter, Rickey E. , Stroud, Zachary, Haynes, Louise , Hillhouse, Maureen, Brady, Kathleen T. , Ling, Walter , Back, Sudie E. , Carter, Rickey E

The American Journal of Drug and Alcohol Abuse | August 22, 2011 | Volume: 37 | Issue: 5 | Pages: 313-323

10.3109/00952990.2011.596982 Get It

Methylphenidate Transdermal System in Adults With Past Stimulant Misuse
McRae‐Clark, Aimee L. , Brady, Kathleen T. , Hartwell, Karen J., White, Kathleen, Carter, Rickey E. , Carter, Rickey E

Journal of Attention Disorders | June 10, 2010 | Volume: 15 | Issue: 7 | Pages: 539-544

10.1177/1087054710371171 Get It

Objective: This 8-week, open-label trial assessed the efficacy of methylphenidate transdermal system (MTS) in 14 adult individuals diagnosed with ADHD and with a history of stimulant misuse, abuse, or dependence. Method: The primary efficacy endpoint was the Wender-Reimherr Adult ADHD Scale (WRAADS), and secondary efficacy endpoints included the Clinical Global Impression (CGI) ratings and substance abuse as quantified by urine drug screens and self-reported use. Results: Significant improvements from baseline were found on both the WRAADS and CGI measurements. No abuse of the study medication was observed. Conclusion: The findings suggested that MTS may improve ADHD symptoms in adults with a history of stimulant misuse; however, there were limitations. The study data showed the need for subsequent randomized studies that further explore findings made in this study.